Dataset from A Phase 3 Study to Investigate the Efficacy and Safety of SYR-322 When Used in Combination With Insulin Preparation in Subjects With Type 2 Diabetes in Japan
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/00002552
下载链接
链接失效反馈官方服务:
资源简介:
To determine the efficacy and safety of SYR-322 (alogliptin) 25-mg, once daily (QD), in patients with diabetes when used in combination with insulin.
创建时间:
2025-12-08



